Total Payments
$135,801
2024 Payments
$23,366
Companies
7
Transactions
204
Medicare Patients
917
Medicare Billing
$244,058
Payment Breakdown by Category
Other$103,466 (76.2%)
Consulting$16,250 (12.0%)
Travel$10,692 (7.9%)
Food & Beverage$3,321 (2.4%)
Research$2,010 (1.5%)
Education$61.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $103,466 | 78 | 76.2% |
| Consulting Fee | $16,250 | 4 | 12.0% |
| Travel and Lodging | $10,692 | 44 | 7.9% |
| Food and Beverage | $3,321 | 63 | 2.4% |
| Unspecified | $2,010 | 7 | 1.5% |
| Education | $61.89 | 8 | 0.0% |
Payments by Type
General
$133,791
197 transactions
Research
$2,010
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $89,212 | 124 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $46,059 | 72 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $200.00 | 1 | $0 (2024) |
| Respicardia, Inc. | $143.56 | 1 | $0 (2019) |
| Gilead Sciences Inc | $140.16 | 3 | $0 (2017) |
| Intuitive Surgical, Inc. | $24.94 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $21.74 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,366 | 32 | United Therapeutics Corporation ($23,166) |
| 2023 | $6,710 | 7 | United Therapeutics Corporation ($6,710) |
| 2022 | $5,397 | 8 | United Therapeutics Corporation ($5,372) |
| 2021 | $9,863 | 10 | United Therapeutics Corporation ($9,841) |
| 2020 | $4,041 | 5 | United Therapeutics Corporation ($4,041) |
| 2019 | $13,782 | 22 | United Therapeutics Corporation ($13,613) |
| 2018 | $31,870 | 55 | Actelion Pharmaceuticals US, Inc. ($19,591) |
| 2017 | $40,772 | 65 | Actelion Pharmaceuticals US, Inc. ($26,442) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $145.43 | General |
| 10/30/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 10/17/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,840.00 | General |
| 10/08/2024 | United Therapeutics Corporation | TYVASO (Drug), REMODULIN, ORENITRAM | Food and Beverage | In-kind items and services | $44.42 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/01/2024 | United Therapeutics Corporation | TYVASO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,270.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/26/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $88.82 | General |
| 09/26/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $79.36 | General |
| 09/23/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Cardio-pulmonary | ||||||
| 09/16/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $47.99 | General |
| 09/16/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $40.31 | General |
| 09/12/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 09/12/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 09/12/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 09/12/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 09/12/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 09/09/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $400.95 | General |
| 09/09/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $15.94 | General |
| 05/22/2024 | United Therapeutics Corporation | REMODULIN (Drug), TYVASO, TYVASO | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 04/17/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,500.00 | General |
| 04/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 04/12/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $563.64 | General |
| 04/10/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $93.70 | General |
| 03/27/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $165.00 | General |
| 03/18/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $883.20 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH IN HEART FAILURE WITH PRESERVED EJECTION FRACTION HFPEF | United Therapeutics Corporation | $1,520 | 4 |
| AN OPEN-LABEL EXTENSION STUDY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION HFPEF - A LONG-TERM FOLLOW-UP TO STUDY TDE-HF-301 | United Therapeutics Corporation | $489.97 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 123 | 249 | $116,876 | $37,542 |
| 2022 | 3 | 186 | 344 | $144,276 | $46,114 |
| 2021 | 4 | 256 | 468 | $198,597 | $67,878 |
| 2020 | 8 | 352 | 666 | $274,374 | $92,524 |
Total Patients
917
Total Services
1,727
Medicare Billing
$244,058
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 57 | 139 | $85,346 | $25,690 | 30.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 97 | $25,212 | $9,891 | 39.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 13 | $6,318 | $1,961 | 31.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 69 | 140 | $85,960 | $26,293 | 30.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 86 | 173 | $43,250 | $15,126 | 35.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $15,066 | $4,696 | 31.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 95 | 204 | $125,256 | $40,520 | 32.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 113 | 213 | $53,250 | $19,988 | 37.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 36 | $17,496 | $6,390 | 36.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 15 | $2,595 | $979.95 | 37.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 119 | 269 | $165,166 | $52,709 | 31.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 122 | 271 | $67,750 | $25,107 | 37.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 39 | 39 | $18,954 | $6,936 | 36.6% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 23 | 24 | $8,424 | $3,141 | 37.3% |
| 31622 | Diagnostic examination of lung airways using an endoscope | Facility | 2020 | 13 | 17 | $6,103 | $2,046 | 33.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 17 | $2,941 | $1,093 | 37.2% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 11 | 11 | $3,344 | $859.04 | 25.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 18 | $1,692 | $633.31 | 37.4% |
About Dr. Tunay Kuru, MD
Dr. Tunay Kuru, MD is a Critical Care Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063411221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tunay Kuru, MD has received a total of $135,801 in payments from pharmaceutical and medical device companies, with $23,366 received in 2024. These payments were reported across 204 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($103,466).
As a Medicare-enrolled provider, Kuru has provided services to 917 Medicare beneficiaries, totaling 1,727 services with total Medicare billing of $244,058. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Washington, DC
- Active Since 07/20/2005
- Last Updated 03/08/2012
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1063411221
Products in Payments
- ORENITRAM (Drug) $26,583
- TYVASO (Drug) $9,978
- OPSUMIT MACITENTAN (Drug) $7,854
- NONE (Drug) $7,652
- REMODULIN (Drug) $5,720
- Adempas (Drug) $200.00
- remede System (Device) $143.56
- Da Vinci Surgical System (Device) $24.94
- VERQUVO (Drug) $21.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Washington
Jonathan Chow, M.d, M.D
Critical Care Medicine — Payments: $328,413
Critical Care Medicine $328,413
Eric Anderson
Critical Care Medicine — Payments: $177,372
Critical Care Medicine $177,372
Anne O'donnell
Critical Care Medicine — Payments: $128,159
Critical Care Medicine $128,159
Dr. Andrew Lerner, Md, MD
Critical Care Medicine — Payments: $18,342
Critical Care Medicine $18,342
Dr. Joseph Parker, M.d, M.D
Critical Care Medicine — Payments: $15,513
Critical Care Medicine $15,513
Dr. Vivek Jain, Md, MD
Critical Care Medicine — Payments: $12,900
Critical Care Medicine $12,900